It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
Neuroleptic malignant-like syndrome (NMLS) is a rare but life threatening and important complication because of the withdrawal of long-term l-Dopa therapy in Parkinson's disease patients. In this case report, we review the pathophysiology, clinical features and treatment of this curable condition.
Douglas
Avion
A
Royal Free Hospital NHS Trust, Pond Street, London NW3, UK. aviondouglas@yahoo.com
Morris
Jackie
J
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology* / Q000628:therapy
D000978:Antiparkinson Agents; D007980:Levodopa